Research press release


Nature Communications

Health: Glial cell transplantation alleviates Huntington's symptoms



今回、Steven Goldmanたちは、いくつかの実験を実施し、16~91匹のマウスの脳にヒトのグリア細胞を移植した。ハンチントン病の原因となる遺伝子変異を有するヒトのグリア細胞を健康な新生仔マウスに移植した実験では、これらのマウスが成体になった時にハンチントン病の症状に似た症状(例えば運動協調性障害)が見られた。一方、健康なヒトのグリア細胞をR6/2マウス(ヒトのハンチントン病に似た症状を示すマウスモデル)の新生仔に移植した実験では、マウスの運動機能と認知機能が有意に改善し、寿命も長くなった。


Transplanting healthy human glial cells - which provide structural support for nerve cells in the brain - into mouse models of Huntington’s disease (HD) improved motor coordination and extended life span in the mice, reports a study published online this week in Nature Communications.

Glial cells, the most abundant cell types in the central nervous system, have received little attention in studies of HD, an inherited neurodegenerative disorder characterized by gradual loss of the nerve cells that control movement, emotions and thoughts.

Steven Goldman and colleagues transplanted human glial cells into the brains of 16 to 91 mice across several experiments. When they transplanted human glial cells carrying the disease-causing gene mutation into healthy newborn mice, they found that these mice showed HD-like symptoms, such as poor motor coordination, when they reached adulthood. On the other hand, when they transplanted healthy human glial cells into newborn R6/2 mice - a mouse model that mimics HD in humans - their motor performance and cognitive functions were significantly improved and they lived longer.

This study suggests that glial cells may play a much more active role in HD than previously thought, thus offering a new perspective for understanding and potentially treating HD. Future studies are needed to further dissect glial dysfunction in HD, and to assess if and how these findings can be translated into treatment for humans.

doi: 10.1038/ncomms11758

「Nature 関連誌注目のハイライト」は、ネイチャー広報部門が報道関係者向けに作成したリリースを翻訳したものです。より正確かつ詳細な情報が必要な場合には、必ず原著論文をご覧ください。

メールマガジンリストの「Nature 関連誌今週のハイライト」にチェックをいれていただきますと、毎週最新のNature 関連誌のハイライトを皆様にお届けいたします。